1st Quarter - Report

WEST FRONT STRATEGIES LLC for VIATRIS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to the intellectual property provisions in the Trans-Pacific Partnership negotiations.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to patent litigation reform, including H.R. 9, the Innovation Act and S. 632, the STRONG Patents Act.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 632 (114th), H.R. 9 (114th)

Budget/Appropriations BUD

FY 2016 Agriculture/FDA Appropriations, in particular, FDA funding and sequestration of user fees; FY 2016 State/Foreign Operations Appropriations, in particular, PEPFAR funding.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to implementation of the Generic Drug User Fee Agreement; Issues related to the 21st Century Cures Initiative and Innovation Initiative; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; FDA proposed rule, Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products; Issues related to generic drug pricing.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
MYLAN NV United Kingdom United Kingdom 100.0% —
MYLAN HOLDINGS LIMITED United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.